Medicine and Dentistry
Ovarian Cancer
100%
Ibrutinib
100%
Bruton Tyrosine Kinase Inhibitor
100%
Bruton Tyrosine Kinase
75%
Cisplatin
75%
Malignant Neoplasm
50%
Cancer Cell
25%
Overall Survival
25%
Upregulation
25%
Cell Marker
25%
Tumor Spheroid
25%
Drug Resistance
25%
Janus Kinase
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Bruton Tyrosine Kinase Inhibitor
100%
Ibrutinib
100%
Cisplatin
75%
Bruton Tyrosine Kinase
75%
Malignant Neoplasm
50%
Overall Survival
25%
Cell Marker
25%
Drug Resistance
25%
Janus Kinase
25%
Biochemistry, Genetics and Molecular Biology
Tyrosine Kinase Inhibitor
100%
Ibrutinib
100%
Bruton Tyrosine Kinase
100%
Cisplatin
75%
Cancer Cell
25%
STAT3
25%
Overall Survival
25%
Upregulation
25%
Tumor Spheroid
25%
Cell Marker
25%
Drug Resistance
25%
Janus Kinase
25%